Tower Research Capital LLC (Trc) Cv Rx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,900 shares of CVRX stock, worth $50,544. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,900
Previous 2,714
43.7%
Holding current value
$50,544
Previous $23,000
113.04%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$53.2 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$26.3 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$11.9 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$11.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$11.3 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $267M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...